CSBR Earnings

Quarterly EPS
$0.10
Q1 2025
$0.05
Q2 2025
$0.33
Q3 2025
$-0.13
Q4 2025
$-0.03
Q1 2026
$0.02
Q2 2026
$-0.02
Q3 2026
$-0.05
Q4 2026
Latest Revenue13.8M
Latest Net Income-667000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q4 2026-$0.0513.8M-667000+12.0%+61.5%
Q3 2026-$0.0216.6M-279000-2.8%-106.1%
Q2 2026$0.0215.0M237.0K+11.5%-60.0%
Q1 2026-$0.0314.0M-466000-0.5%-130.0%
Q4 2025-$0.1312.4M-1835000-11.8%-1,200.0%
Q3 2025$0.3317.0M4.5M+41.8%+273.7%
Q2 2025$0.0513.5M728.0K+16.6%+133.3%
Q1 2025$0.1014.1M1.3M+11.9%+152.6%
Q4 2024-$0.0114.0M-109000
Q3 2024-$0.1912.0M-2530000
Q2 2024-$0.1511.6M-2071000
Q1 2024-$0.1912.6M-2566000
Champions Oncology (CSBR) — Earnings